Summary:
In patients with type 2 diabetes mellitus (T2DM) and cognitive decline, Huayu Tongluo moxibustion combined with routine hypoglycemic treatment significantly improved cognitive function and reduced insulin resistance compared to routine hypoglycemic treatment alone (waiting moxibustion group), though it was associated with no reported side effects.
| PICO | Description |
|---|---|
| Population | Ninety adult patients diagnosed with type 2 diabetes mellitus (T2DM) and exhibiting cognitive decline. |
| Intervention | Huayu Tongluo moxibustion applied every other day for 12 weeks at Baihui (GV20), Shenting (GV24), and Dazhui (GV14) in addition to standard hypoglycemic therapy. |
| Comparison | Routine hypoglycemic treatment alone (waiting moxibustion group), without active moxibustion intervention during the treatment period. |
| Outcome | Significant improvements in MoCA, MMSE, ACE-III (total and subscales: attention, memory, language fluency), SDMT scores (P<0.05 or P<0.01), and reductions in AIS and HOMA-IR were observed in the moxibustion group post-treatment and at 12-week follow-up. Improvements were superior to those in the control group. |
Source: Min Ye, et al. “Effects of Huayu Tongluo moxibustion on cognitive function and insulin resistance in patients with type 2 diabetes mellitus and cognitive decline: a randomized controlled trial.” Read article here.
